DexCom (DXCM)
(Delayed Data from NSDQ)
$112.13 USD
+0.48 (0.43%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $112.47 +0.34 (0.30%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Brokerage Reports
0 items in cart
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 401 - 414 ( 414 total )
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Financials Meet Expectations. SEVEN PLUS Demand Remains Strong and New Product Launches Anticipated.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Preview: We are at the Mid-Range of Consensus and Believe Our Estimates are Achievable.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
70TH ANNUALAMERICAN DIABETES ASSOCIATION MEETING CONFIRMS THESIS - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Life Sciences: Biopharmaceuticals / Biotechnology.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L